Keryx Pharmaceuticals Private Limited
About Keryx Pharmaceuticals Private Limited
Data last updated:
Keryx Pharmaceuticals Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 05 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2007PTC030937. Its GSTIN is 01AADCK1283H1ZY (Jammu and Kashmir).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajay Mengi and Renu Mengi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 488 Industrial Area Phase 9, Mohali, Punjab, India – 144003.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.46 Lakh, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹2,891 (net margin 0.1%) and EBITDA of ₹1.6 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹40 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered Address488 Industrial Area Phase 9, Mohali, Punjab, India – 144003
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Keryx Pharmaceuticals Private Limited
The main business activity of Keryx Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Keryx Pharmaceuticals Private Limited FY 2025 filings available
Keryx Pharmaceuticals Private Limited reported revenue of ₹30.46 Lakh (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Keryx Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 33% growth in the latest year. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Keryx Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.6 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2,891 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Keryx Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Keryx Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Keryx Pharmaceuticals Private Limited
Keryx Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Mengi | Director | 05 Mar 2007 | 19 Years 7 Months | Current |
| Renu Mengi | Director | 19 Mar 2011 | 15 Years 7 Months | Current |
Peer Comparison of Keryx Pharmaceuticals Private Limited
Keryx Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| NRXN Pharmaceuticals Private Limited | ₹30.68 Lakh (FY 2024) | •••• | •••• | 2.0% | •••• | Bareilly, Uttar Pradesh, India |
| Atrisma Pharmaceuticals Private Limited | ₹30.67 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Muzaffarpur, Bihar, India |
| RX Plus Pharmaceuticals Private Limited | ₹30.63 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Accipere Pharmaceuticals Private Limited | ₹30.61 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Kollam, Kerala, India |
| Macnis Pharmaceuticals Private Limited | ₹30.55 Lakh (FY 2023) | •••• | •••• | 27.0% | •••• | Delhi, India |
| Keryx Pharmaceuticals Private Limited this company | ₹30.46 Lakh (FY 2025) | •••• | •••• | 33.0% | •••• | Mohali, Punjab, India |
| Ackrose Pharmaceuticals Private Limited | ₹30.44 Lakh (FY 2025) | •••• | •••• | -35.0% | •••• | Delhi, India |
| Bioclinical Pharmaceuticals Private Limited | ₹30.41 Lakh (FY 2022) | •••• | •••• | 47.0% | •••• | Pune, Maharashtra, India |
| Strebi Pharmaceuticals Private Limited | ₹30.4 Lakh (FY 2025) | •••• | •••• | -59.0% | •••• | Jagadhari, Haryana, India |
| Maxelon Pharmaceuticals Private Limited | ₹30.23 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Naini, Uttar Pradesh, India |
| Thebes Pharmaceuticals Private Limited | ₹30.2 Lakh (FY 2025) | •••• | •••• | 58.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Keryx Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Keryx Pharmaceuticals Private Limited
Keryx Pharmaceuticals Private Limited is audited by Rakesh Ganesh & Associates for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Rakesh Ganesh & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Keryx Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Keryx Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Feb 2016 | Others | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Keryx Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Keryx Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Keryx Pharmaceuticals Private Limited
Keryx Pharmaceuticals Private Limited has 3 board changes on record since 2007: 2 appointments and 1 cessation. The latest: Sanjeev Singh Bagal ceased to be Director on 21 Mar 2011.
Credit Ratings, Litigation & Regulatory Alerts for Keryx Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Keryx Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Keryx Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Keryx Pharmaceuticals Private Limited
Keryx Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01AADCK1283H1ZY | Jammu and Kashmir | Active | 08 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Keryx Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Keryx Pharmaceuticals Private Limited
Keryx Pharmaceuticals is an active private limited company based in Mohali, Punjab, India. The company works in wholesale, within the trading industry. It was incorporated on 05 March 2007 (19+ years old) and is registered under CIN U24232PB2007PTC030937.
Keryx Pharmaceuticals reported revenue of ₹30.46 Lakh for FY 2025 (up 33% YoY).
Keryx Pharmaceuticals has 2 current directors:
- Ajay Mengi - Director
- Renu Mengi - Director
Keryx Pharmaceuticals reported a net profit of ₹2,891 (net margin 0.1%) and EBITDA of ₹1.6 Lakh (EBITDA margin 5.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Keryx Pharmaceuticals is 10% over three years and 2% over five years. In the latest year (FY 2025) revenue rose 33%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Keryx Pharmaceuticals is 01AADCK1283H1ZY, registered in Jammu and Kashmir.
The CIN (Corporate Identification Number) of Keryx Pharmaceuticals is U24232PB2007PTC030937. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Keryx Pharmaceuticals was incorporated on 05 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Keryx Pharmaceuticals by revenue are NRXN Pharmaceuticals Private Limited, Atrisma Pharmaceuticals Private Limited, RX Plus Pharmaceuticals Private Limited, Accipere Pharmaceuticals Private Limited, Macnis Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Sanjeev Singh Bagal ceased to be Director on 21 Mar 2011. Renu Mengi was appointed as Director on 19 Mar 2011. Ajay Mengi was appointed as Director on 05 Mar 2007.
The registered office of Keryx Pharmaceuticals is at 488 Industrial Area Phase 9, Mohali, Punjab, India – 144003.